Cardiovascular Diseases

Effects of A Ketogenic Diet, Time-Restricted Eating or Alternate-Day Fasting on Ambulatory BP

A sub-analysis of a Spanish randomized clinical trial showed that diets with varying ketogenic potential had differing impacts on blood pressure (BP). Ninety six participants with obesity (BMI >30 kg/m²) were assigned to one of five dietetic interventions: early time-restricted eating (eTRE), late time-restricted eating (lTRE), modified alternate-day fasting (mADF), ketogenic diet (KD), or a control Mediterranean diet (CG). All groups achieved significant improvements in anthropometric measures, but BP responses differed. The mADF group showed the most effective improvements in 24-hour ambulatory BP monitoring, while lTRE also demonstrated some benefits. In contrast, KD, eTRE, and CG did not produce statistically significant changes. The findings suggests that Low-calorie diets with different ketogenic potentials can reduce BP in people with obesity, especially mADF. Source: https://academic.oup.com/eurjpc

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.